Pontine glioma
Showing 26 - 50 of 979
Samples From Diffuse Intrinsic Pontine Glioma and Brainstem
Recruiting
- Diffuse Intrinsic Pontine Glioma
- Brainstem Glioma
-
Washington, District of ColumbiaChildren's National Medical Center
Nov 1, 2021
DIPG Trial (131I-Omburtamab, Convention Enhanced Delivery)
Not yet recruiting
- DIPG
- 131I-Omburtamab
- Convention Enhanced Delivery
- (no location specified)
Feb 7, 2022
Malignant Glioma, Ependymoma Trial in United States (Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields))
Active, not recruiting
- Malignant Glioma
- +2 more
- Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)
- Concurrent Optune and RT followed by Optune System alone
-
Los Angeles, California
- +8 more
Jan 17, 2023
Neuroblastoma, Diffuse Intrinsic Pontine Glioma Trial in Gainesville, Charlotte (Tumor-specific ex vivo expanded autologous
Recruiting
- Neuroblastoma
- Diffuse Intrinsic Pontine Glioma
- Tumor-specific ex vivo expanded autologous lymphocyte transfer (TTRNA-xALT)
-
Gainesville, Florida
- +1 more
Apr 20, 2022
Glioblastoma, Diffuse Intrinsic Pontine Glioma Trial in Japan (DSP-7888)
Completed
- Glioblastoma
- Diffuse Intrinsic Pontine Glioma
-
Nagoya, Aichi, Japan
- +5 more
Apr 9, 2022
Diffuse Intrinsic Pontine Glioma, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Switzerland, United States
Active, not recruiting
- Diffuse Intrinsic Pontine Glioma
- +4 more
- Fimepinostat
- Therapeutic Conventional Surgery
-
Los Angeles, California
- +18 more
Aug 16, 2022
Diffuse Intrinsic Pontine Glioma, Glioma, Malignant Trial in United States (ONC201)
Recruiting
- Diffuse Intrinsic Pontine Glioma
- Glioma, Malignant
-
San Francisco, California
- +7 more
Mar 1, 2022
Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, High Grade Glioma Trial run by the NCI (Lenalidomide, XRT, 54-59.4 Gy)
Completed
- Diffuse Intrinsic Pontine Glioma
- +2 more
- Lenalidomide
- XRT, 54-59.4 Gy
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 30, 2021
High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))
Recruiting
- High Grade Glioma
- +12 more
- LUTATHERA® (Lutetium Lu 177 dotatate)
-
Aurora, Colorado
- +8 more
Jan 16, 2023
Diffuse Intrinsic Pontine Glioma, Diffuse Pontine and Thalamic Gliomas, Diffuse Midline Glioma, H3 K27M-Mutant Trial in New York
Active, not recruiting
- Diffuse Intrinsic Pontine Glioma
- +2 more
- Panobinostat 15 MG
- Focused Ultrasound with neuro-navigator-controlled sonication
-
New York, New YorkColumbia University Irving Medical Center / NewYork-Presbyterian
Feb 3, 2022
Diffuse Intrinsic Pontine Glioma (DIPG) Trial in United States (Specialized tumor board recommendation, Standard radiation
Completed
- Diffuse Intrinsic Pontine Glioma (DIPG)
- Specialized tumor board recommendation
- Standard radiation therapy
-
San Diego, California
- +4 more
Nov 2, 2022
High Grade Glioma, Diffuse Intrinsic Pontine Glioma Trial in Edegem (Dendritic cell vaccination + temozolomide-based
Recruiting
- High Grade Glioma
- Diffuse Intrinsic Pontine Glioma
- Dendritic cell vaccination + temozolomide-based chemoradiation
- Dendritic cell vaccination +- conventional next-line treatment
-
Edegem, BelgiumUnitversity Hospital Antwerp
Sep 13, 2021
Diffuse Intrinsic Pontine Glioma, Diffuse Pontine and Thalamic Gliomas, Diffuse Midline Glioma Trial in New York (Infusate with
Recruiting
- Diffuse Intrinsic Pontine Glioma
- +2 more
- Infusate with MTX110 and gadolinium
- Convection-Enhanced Delivery (CED)
-
New York, New YorkColumbia University Irving Medical Center
Mar 8, 2022
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Recurrent Medulloblastoma Trial in United States (PEP-CMV, Temozolomide,
Not yet recruiting
- High Grade Glioma
- +2 more
- PEP-CMV
- +2 more
-
Aurora, Colorado
- +9 more
Jan 28, 2022
Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester
Active, not recruiting
- Childhood Astrocytoma
- +9 more
- Laboratory Biomarker Analysis
- +2 more
-
Rochester, MinnesotaMayo Clinic
Sep 8, 2022
Brain Tumor, Pediatric, Medulloblastoma, Childhood, Embryonal Tumor Trial (GD2-CART01 (iC9-GD2-CAR T-cells))
Not yet recruiting
- Brain Tumor, Pediatric
- +6 more
- GD2-CART01 (iC9-GD2-CAR T-cells)
- (no location specified)
Mar 18, 2022
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 2, 2023
Diffuse Intrinsic Pontine Glioma (DIPG), Brain Stem Glioma Trial in Gainesville (TTRNA-DC vaccines with GM-CSF, TTRNA-xALT,
Recruiting
- Diffuse Intrinsic Pontine Glioma (DIPG)
- Brain Stem Glioma
- TTRNA-DC vaccines with GM-CSF
- +5 more
-
Gainesville, FloridaUF Health Shands Children's Hospital
Apr 29, 2022
International Diffuse Intrinsic Pontine Glioma/Diffuse Midline
Recruiting
- Diffuse Intrinsic Pontine Glioma
- +2 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jun 18, 2021
Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Embryonal Tumor Trial in Houston ((C7R)-GD2.CART cells, Cyclophosphamide,
Recruiting
- Diffuse Intrinsic Pontine Glioma
- +3 more
- (C7R)-GD2.CART cells
- +2 more
-
Houston, TexasTexas Children's Hospital
Feb 7, 2022
Recurrent or Progressive Diffuse Intrinsic Pontine Glioma Trial in Australia, Canada, New Zealand (re-irradiation)
Recruiting
- Recurrent or Progressive Diffuse Intrinsic Pontine Glioma
- re-irradiation
-
Westmead, New South Wales, Australia
- +17 more
Dec 14, 2021
Recurrent Diffuse Intrinsic Pontine Glioma Trial in Cincinnati (Hypofractionated Radiotherapy)
Enrolling by invitation
- Recurrent Diffuse Intrinsic Pontine Glioma
- Hypofractionated Radiotherapy
-
Cincinnati, OhioUniversity of Cincinnati
Jul 1, 2021
Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)
Terminated
- Glioma
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan Cancer Center
Sep 26, 2022